BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12910741)

  • 1. Update on antifungal therapy.
    Grooters AM; Taboada J
    Vet Clin North Am Small Anim Pract; 2003 Jul; 33(4):749-58, vi. PubMed ID: 12910741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal treatment of small animal veterinary patients.
    Foy DS; Trepanier LA
    Vet Clin North Am Small Anim Pract; 2010 Nov; 40(6):1171-88. PubMed ID: 20933143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
    van 't Wout JW; Kuijper EJ; Verweij PE; Kullberg BJ
    Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1679-84. PubMed ID: 15453120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspofungin versus amphotericin B for invasive candidiasis.
    Brown AL; Greig JR
    N Engl J Med; 2003 Mar; 348(13):1287-8; author reply 1287-8. PubMed ID: 12660396
    [No Abstract]   [Full Text] [Related]  

  • 5. Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate.
    Goodman D; Pamer E; Jakubowski A; Morris C; Sepkowitz K
    Clin Infect Dis; 2002 Aug; 35(3):E35-6. PubMed ID: 12115115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal agents in children.
    Steinbach WJ
    Pediatr Clin North Am; 2005 Jun; 52(3):895-915, viii. PubMed ID: 15925667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New antifungal agents-treatment standards are beginning to grow old.
    Maschmeyer G
    J Antimicrob Chemother; 2002 Feb; 49(2):239-41. PubMed ID: 11815563
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical relevance of mechanisms of antifungal drug resistance in filamentous fungi].
    Mellado E; Cuenca-Estrella M; Rodríguez-Tudela JL
    Enferm Infecc Microbiol Clin; 2002 Dec; 20(10):523-29; quiz 530, 539. PubMed ID: 12433354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comment: caspofungin acetate for treatment of invasive fungal infections.
    Chan J
    Ann Pharmacother; 2003 Apr; 37(4):595. PubMed ID: 12659624
    [No Abstract]   [Full Text] [Related]  

  • 10. Progressive cutaneous hyalohyphomycosis due to Paecilomyces lilacinus: rapid response to treatment with caspofungin and itraconazole.
    Safdar A
    Clin Infect Dis; 2002 May; 34(10):1415-7. PubMed ID: 11981740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic antifungals. Pharmacodynamics and pharmacokinetics].
    Catalán M; Montejo JC
    Rev Iberoam Micol; 2006 Mar; 23(1):39-49. PubMed ID: 16499430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
    Almyroudis NG; Sutton DA; Fothergill AW; Rinaldi MG; Kusne S
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2587-90. PubMed ID: 17452481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Caspofungin in the replacement of amphotericin B in the treatment of fungal diseases].
    Yang W; He B
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):53. PubMed ID: 15808079
    [No Abstract]   [Full Text] [Related]  

  • 14. [The future of antifungal agents].
    Maesaki S
    Rinsho Ketsueki; 2007 Jan; 48(1):26-35. PubMed ID: 17313074
    [No Abstract]   [Full Text] [Related]  

  • 15. Caspofungin versus liposomal amphotericin B for empirical therapy.
    Tattevin P; Bareau B; Camus C
    N Engl J Med; 2005 Jan; 352(4):410-4; author reply 410-4. PubMed ID: 15675091
    [No Abstract]   [Full Text] [Related]  

  • 16. Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections.
    Groll AH; Walsh TJ
    Expert Opin Investig Drugs; 2001 Aug; 10(8):1545-58. PubMed ID: 11772269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspofungin: the first representative of a new antifungal class.
    Letscher-Bru V; Herbrecht R
    J Antimicrob Chemother; 2003 Mar; 51(3):513-21. PubMed ID: 12615851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updated information for treatment of fungal infections in cats and dogs.
    Ben-Ziony Y; Arzi B
    J Am Vet Med Assoc; 2001 Jun; 218(11):1718. PubMed ID: 11394811
    [No Abstract]   [Full Text] [Related]  

  • 19. Antifungal activity of itraconazole and voriconazole against clinical isolates obtained from animals with mycoses.
    Okabayashi K; Imaji M; Osumi T; Murakami Y; Maruyama H; Kano R; Hasegawa A; Watanabe T
    Nihon Ishinkin Gakkai Zasshi; 2009; 50(2):91-4. PubMed ID: 19430183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of mycoses and new antifungal agents].
    Dupont B
    Rev Prat; 1989 Sep; 39(19):1688-94. PubMed ID: 2554481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.